An observational study in Chronic Pain, sponsored by Université de Sherbrooke. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-12.
Sponsored by Université de Sherbrooke · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Chronic Pain by Université de Sherbrooke — 8 open to participants now, 9 under way, none of them phase 3. Chronic Pain · Université de Sherbrooke.
Among the 15 studies in Chronic Pain by Université de Sherbrooke, this one is the only one that started in 2021, is one of 4 observational ones, and was the 6th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →8 of the 15 studies in Chronic Pain by Université de Sherbrooke are open now, in 1 country. Recruiting first, the newest first:
Université de Sherbrooke · Sites in Canada
Ages 18+
Université de Sherbrooke · Sites in Canada
Ages 65+
Université de Sherbrooke · Sites in Canada
Ages 55+
Université de Sherbrooke · Sites in Canada
Ages 56+
Université de Sherbrooke · Sites in Canada
Ages 60+
By country, each count listing its studies:
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 1 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 120 across 755 observational studies indexed under Chronic Pain.
Median enrollment 32 across the 11 interventional studies, 137 across the 4 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Université de Sherbrooke is the lead sponsor of 298 studies on the registry; 67 are open to participants now.
1 of the studies in Chronic Pain by Université de Sherbrooke that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07137845Université de SherbrookeVirtual Reality and Cranial Nerve Non-invasive Neuromodulation to Improve Quality of Life for Veterans | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in Chronic Pain by Université de Sherbrooke, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Physical exercises and transcranial direct current stimulation (tDCS) are both known to reduce chronic pain in structured laboratory studies. The aim of this study is to assess the efficacy of this combined treatment in clinical settings.
Chronic pain patients who are going to the physiotherapy clinic to receive tDCS treatment sessions are evaluated in order to assess the efficacy of tDCS in clinical settings. Physiotherapists prescribe physical exercises adapted to the patients conditions. Patients performed their physical exercises every time they received a tDCS treatment, but were also recommended to continue their physical exercises program at home after completion of physiotherapy visits.
Concerning tDCS treatment, patients were encouraged to receive 1 tDCS session per day for 5 consecutive days.
All patients that received tDCS sessions in clinical settings
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
5 daily sessions of tDCS (2mA, 20 min) were recommended to all patients. Physical exercises were also done at the physiotherapy clinic. Physical exercises program was recommended to be continued at home after the week of physiotherapy visits.
Also known as: tDCS
Change in McGill pain Questionnaire
qualitative and quantitative aspects of pain
Time frame: Baseline, 1 week, 1 month
Change in Brief Pain Inventory
Physical Function
Time frame: Baseline, 1 week, 1 month
Change in Tampa Questionnaire
Kinesiophobia
Time frame: Baseline, 1 week, 1 month
Change in Beck Depression Inventory
Depression
Time frame: Baseline, 1 week, 1 month
Change in Patient global impression of change
Impression of change
Time frame: 1 week, 1 month
Number of sessions received
Feasibility; did the patients received all their tDCS sessions in 5 days (1 per day)
Time frame: Through study completion, an average of 5 days
Side effect
Side effect reported by the patients (headache, dizziness, fatigue, nausea, redness, tingling)
Time frame: Through study completion, an average of 5 days
Ran from Jan 2021 to primary completion in Feb 2021, 1 month.
Of 337 non-industry observational studies under Chronic Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 56. This study's 1 month is below that.
Counting every sponsor, half of 363 studies reached it within 24 months; a quarter within 12 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.